期刊文献+

肝素和氢化可的松对人非小细胞肺癌移植瘤模型作用的实验研究 被引量:1

The inhibitory effect of the combination of heparin and hydrocortisone on growth of human non-small-cell lung cancer in vivo
暂未订购
导出
摘要 目的 观察肝素和氢化可的松对人非小细胞肺癌(NSCLC)移植瘤模型的抗血管生成作用。方法Balb-c裸鼠30只 ,均接种Calu -6细胞 ,随机分为3组 ,每组10只。A组 :第10~30天、第40天至实验结束饮水内加入肝素500IU/ml、氢化可的松0.45mg/ml。B组 :第10~14天、第31~35天腹腔内注射卡铂10mg/(kg·d)。C组 :对照组 ,不进行任何治疗。观察各时点肿瘤体积的变化 ,并检测细胞凋亡、增殖细胞核抗原(PCNA)、血管内皮生长因子(VEGF)蛋白、VEGFmRNA阳性细胞数和血管内皮细胞粘附分子 -1(CD31)染色阳性血管数等。 结果 A组在治疗第2、3、4、8周时肿瘤体积均小于C组(均P<0.05) ,第2周时肿瘤体积大于B组(P<0.05)。A组在凋亡细胞、PCNA、VEGF蛋白与VEGFmRNA阳性细胞数和CD31阳性血管数等方面都与B、C组有明显差别(均P<0.05)。 结论 肝素和氢化可的松联合应用能够有效抑制Calu -6细胞在体内的生长。 Objective To observe the anti _ angiogenetic effect of heparin and hydrocortisone in Calu-6 human non _ small _ cell lung cancer(NSCLC) of nude mice.Methods Xenograft tumors were established by subcutaneous injection of Calu _ 6 cells into 30 nude _ mice.The animals were divided randomly into 3 groups:group A,the mice were administrated with heparin (500IU/ml) and hydrocortisone (0.45mg/ml) in the drinking water from the 10th day to the 30th day and from the 40th day to the end of the trial;group B,the mice were treated with carboplatin 10mg/(kg·d) at 10th to 14th and 31st to 35th day;group C,the mice were injected with Calu-6 cells and without any treatment.The volumes of tumors were observed.The number of apoptosis cells and VEGF (vascular endothelial growth factor) -positive cells and VEGF mRNA and proliferating cell nuclear antigen (PCNA) and the number of vascular endothelial cell adhesion molecule-1 (CD 31) positive vascular were detected. Results The mean tumor volume of group A had significant difference with group C at the time of 2nd,3rd,4th and 8th week (P<0.05).The number of apoptosis cells,PCNA,the number of VEGF- positive cells and VEGF mRNA and the positive vessel number of CD 31 of group A had significant difference with those of group B and C (P<0.05).Conclusion The combination of heparin and hydrocortisone can effectively inhibit the growth of xenograft Calu-6 cells in vivo.
出处 《浙江医学》 CAS 2003年第1期16-18,23,共4页 Zhejiang Medical Journal
关键词 肝素 氢化可的松 非小细胞肺癌 移植瘤 实验研究 NSCLC VEGF Apoptosis Anti-angiogensis Nude-mice
  • 相关文献

参考文献8

  • 1Boring CC, Squires TS, Tong T. Cancer statistics. Chem. Abstr, 1994,44(1): 7.
  • 2Folkman J,Langer R,Linhardt RJ,et al. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science, 1983,221 (16): 719.
  • 3Jung SP,Siegrist B,Wade MR, et al. Inhibition of human angiogenesis with heparin and hydrocortisone. Angiogenesis, 2001,4(3): 175.
  • 4Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Natur Med, 1995,1 (1): 27.
  • 5张鹏,尹珺,刘毅梅.肝素和氢化可的松对血管内皮细胞和成纤维细胞的生长抑制作用[J].中国肿瘤临床,2001,28(6):418-421. 被引量:2
  • 6蒋栋良 刘兰珍.口服肝素与可的松抑制移植瘤S180生长[J].肿瘤,1986,6(6):268-268.
  • 7程树群,周信达,汤钊猷,余耀,鲍苏苏,钱德初.高功率聚焦超声联合肝素可的松治疗肝癌的实验研究[J].中华消化杂志,1999,19(1):10-12. 被引量:11
  • 8Nauck M, Karakiulakis G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol, 1998,341 (2 ~ 3):309.

二级参考文献10

共引文献11

同被引文献9

  • 1Nakamura T M,Morin G B.Chapman K B .et al.Telomerase catalytic subunit homologs from fission yeast and human[J].Science,1997.277(33):955-959.
  • 2Engelberg H.Actions of heparin that may affect the malignant process[J].Cancer,1999.85(2):257-272.
  • 3Borsig L.Wong R.Feramisco J,et al.Heparin and cancer revisited:mechanistic connections involving platelets,P-selectin.carcinoma mucis,and tumor metastasis[J].Proc Natl Acad Sci U S A.2001,98(6):3352-3357.
  • 4Varki N M,Varki A.Heparin inhibition of selectin-Mediated interactions during the hematogenous phase of carcinoma metastasis:rationale for clincal studies in humans[J].Semin Thromb Hemost,2002,28(1):53-66.
  • 5Yamaguchi F,Morrison R S.Takahashi H,et al.Anti-telomerase therapy suppressed glioma proliferation[J].Oncol Rep,1999.6(4):773-776.
  • 6Kunifuji Y.Gotoh S,Abe T,et al.Down-regulation of telomerase activity by anticancer drugs in human ovarian cancer cells[J].Anticancer Drugs,2002,13(6):595-598.
  • 7Rowley P T,Tabler M.Telomerase inhibitors[J].Anticancer Res,2000,20(6):4419-4429.
  • 8张红梅,张丽珊.端粒酶活性抑制的研究进展[J].国外医学(遗传学分册),2000,23(3):130-133. 被引量:5
  • 9钱晓彬,曹友清,陈淼.端粒酶与食管癌[J].肿瘤防治杂志,2002,9(1):108-110. 被引量:4

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部